Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Anti-CD20-Mediated B Cell Depletion Is Associated with Reduced Osteoclastogenic Signals and Bone Mass Preservation: Clinical Observation in Patients with Follicular Lymphoma Supplemented By Animal Studies in a Murine Model

Albert Kolomansky, MD, Irit Kay, MD, Nathalie Ben-Califa, PhD, Anton Gorodov, BSc, Zamzam Awida, BSc, Ofer Sadovnic, MD, Maria Ibrahim, BSc, Tamar Liron, PhD, Sahar Hiram-Bab, PhD, Howard S. Oster, MD PhD, Nadav Sarid, MD, Chava Perry, MD PhD, Yankel Gabet, DMD, PhD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2020) 136 (Supplement 1): 13.

https://doi.org/10.1182/blood-2020-142295

Published: 2020

Journal Articles

B Cell Specific Knockdown of the Erythropoietin (EPO) Receptor Attenuates EPO-Induced Bone Loss in Mice

Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Nathalie Ben-Califa, PhD, Zamzam Awida, Maria Ibrahim, B.Sc., Tamar Liron, PhD, Sahar Hiram-Bab, PhD, Howard S. Oster, MD PhD, Moshe Mittelman, MD, Martina Rauner, PhD, Ben Wielockx, PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2019) 134 (Supplement_1): 939.

https://doi.org/10.1182/blood-2019-127092

Published: 2019

Journal Articles

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Blood (2018) 132 (Supplement 1): 4357.

https://doi.org/10.1182/blood-2018-99-111838

Published: 2018

Journal Articles

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Sahar Hiram-Bab, PhD, Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Nathalie Ben-Califa, PhD, Tamar Liron, PhD, Martina Rauner, PhD, Ben Wielockx, PhD, Moshe Mittelman, MD, Howard S. Oster, MD PhD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2018) 132 (Supplement 1): 846.

https://doi.org/10.1182/blood-2018-99-111643

Published: 2018

Journal Articles

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Albert Kolomansky, MD, Naamit Deshet-Unger, PhD, Alina Ostrovsky, Nathalie Ben-Califa, PhD, Sahar Hiram-Bab, PhD, Tamar Liron, PhD, Howard S. Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2017) 130 (Supplement 1): 5642.

https://doi.org/10.1182/blood.V130.Suppl_1.5642.5642

Published: 2017

Journal Articles

Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

Blood (2017) 130 (Supplement 1): 2975.

https://doi.org/10.1182/blood.V130.Suppl_1.2975.2975

Published: 2017

Journal Articles

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Howard S Oster, MD PhD, Naamit Deshet-Unger, MSc, Drorit Neumann, PhD, Moshe Mittelman, MD, Nir Maaravi, MD, Sara Prutchi-Sagiv, PhD, Golishevski Nataliya, MD

Blood (2016) 128 (22): 3165.

https://doi.org/10.1182/blood.V128.22.3165.3165

Published: 2016

Journal Articles

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Kolomansky Albert, MD, Sahar Hiram-Bab, PhD, Naamit Deshet-Unger, MSc, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 2445.

https://doi.org/10.1182/blood.V128.22.2445.2445

Published: 2016

Journal Articles

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Nathalie Ben-Califa, PhD, Dafna Gilboa, MSc, Tamar Liron, PhD, Kolomansky Albert, MD, Howard S Oster, MD PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2016) 128 (22): 5043.

https://doi.org/10.1182/blood.V128.22.5043.5043

Published: 2016

Journal Articles

An Active Intervention Has Reduced RBC Transfusion Number: A Single Center Expierience

Ilya Kirgner, MD, Mara Hareuveni, PhD, Yael Sagy, PhD, Ahuva Weiss-Meilik, PhD, Howard S Oster, MD PhD, Irit Avivi, MD, Gabriel Barabash, MD, Moshe Mittelman, MD

Blood (2016) 128 (22): 5040.

https://doi.org/10.1182/blood.V128.22.5040.5040

Published: 2016

Journal Articles

Erythropoietin May Affect B-Cell Maturation and Plasma Cell Antibody Production in Mice

Howard S Oster, MD PhD, Naamit Deshet-Unger, MS, Max Gassmann, DVM, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2015) 126 (23): 4620.

https://doi.org/10.1182/blood.V126.23.4620.4620

Published: 2015

Journal Articles

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Naamit Deshet-Unger, MSc, Sahar Hiram-Bab, PhD, Mor Gross, Yasmin Haim-Ohana, Miriam C. Souroujon, PhD, Howard S. Oster, MD, PhD, Moshe Mittelman, MD, Yankel Gabet, DMD, PhD, Drorit Neumann, PhD

Blood (2013) 122 (21): 1849.

https://doi.org/10.1182/blood.V122.21.1849.1849

Published: 2013

Journal Articles

Azacitidine and Lenalidomide Combination In Higher-Risk Myelodysplastic Syndromes-Preliminary Results Of The Vilen-01 Protocol

Moshe Mittelman, MD, Kalman Filanovsky, MD, Hanna Rosenbaum, MD, Pia Raanani, MD, Andrei Braester, MD, Neta Goldschmidt, MD, Ilana Hellman, PhD, Ilya Kirgner, MD, Chava Perri, Howard S Oster, MD, PhD

Blood (2013) 122 (21): 1576.

https://doi.org/10.1182/blood.V122.21.1576.1576

Published: 2013

Journal Articles

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels: A Preliminary Study in Hematologic Patients

Howard S Oster, MD, PhD, Moran Gvili, BA, Odelia Katz, PhD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2011) 118 (21): 4793.

https://doi.org/10.1182/blood.V118.21.4793.4793

Published: 2011

Journal Articles

Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.

Odelia Katz, PhD, Matthew Stuible, Nataliya Golishevski, MD, Lilach Lifshitz, MD/PhD-student, Michel Tremblay, PhD, FRSC, Max Gassman, PhD, Howard S Oster, MD, PhD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2009) 114 (22): 4557.

https://doi.org/10.1182/blood.V114.22.4557.4557

Published: 2009

Journal Articles

Erythropoietin Treatment Is Associated with Augmented Immune Response to the Influenza Vaccine in Hematologic Patients.

Howard S Oster, MD, PhD, Sara Prutchi-Sagiv, PhD, Ora Halutz, Nataliya Golishevski, MD, Moshe Binyamin, MD, Ruth Orkin, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2009) 114 (22): 1637.

https://doi.org/10.1182/blood.V114.22.1637.1637

Published: 2009

Journal Articles

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Odelia Katz, MSc, Howard S. Oster, MD PhD, Elizabeth Naparstek, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 2675.

https://doi.org/10.1182/blood.V108.11.2675.2675

Published: 2006

Journal Articles

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Sara Prutchi-Sagiv, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Odelia Katz, MSc, Naparstek Elizabeth, MD, Amos Cohen, MD, Michael Hoffman, MD, Drorit Neumann, PhD, Moshe Mittelman, MD

Blood (2006) 108 (11): 3499.

https://doi.org/10.1182/blood.V108.11.3499.3499

Published: 2006

Journal Articles

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Odelia Katz, MSc, Nataliya Golishevski, MD, Howard S. Oster, MD, PhD, Lilach Lifshitz, BSc, Sari Prutchi-Sagiv, MSc, Michael Hoffman, MD, Moshe Mittelman, MD, Drorit Neumann, PhD

Blood (2006) 108 (11): 4228.

https://doi.org/10.1182/blood.V108.11.4228.4228

Published: 2006

NARROW

Anti-CD20-Mediated B Cell Depletion Is Associated with Reduced Osteoclastogenic Signals and Bone Mass Preservation: Clinical Observation in Patients with Follicular Lymphoma Supplemented By Animal Studies in a Murine Model

B Cell Specific Knockdown of the Erythropoietin (EPO) Receptor Attenuates EPO-Induced Bone Loss in Mice

MDS Diagnosis: Many Patients May Not Require Bone Marrow Examination

Erythropoietin (EPO) Regulates Bone Mass Via EPO Receptors on Myeloid and Lymphocytic Cells

Depletion of Mature B Cells By Anti CD20-Directed Antibody Induces Trabecular Bone Loss in Young Mice: An Alert for Clinicians?

Can We Diagnose MDS without Bone Marrow Examination? a Proposed EUMDS-Based Non-Invasive Diagnostic Model

Immune Dysfunction in Patients with MDS Is Partially Corrected in EPO-Treated Patients: Differences According to WHO Classification

Recombinant Erythropoietin and Darbepoetin Alpha Exert a Similar Dose-Dependent Osteopenic Effect Which May Advocate for "Start Low, Go Slow" Dosing Strategy in Clinical Practice

Transdifferentiation of Bone Marrow Pro-B Cells into Bone-Resorbing Osteoclasts- an Unexpected Role for Erythropoietin

An Active Intervention Has Reduced RBC Transfusion Number: A Single Center Expierience

Erythropoietin May Affect B-Cell Maturation and Plasma Cell Antibody Production in Mice

Erythropoietin Potentiates The Immune System Yet Induces Bone Resorption In a Myeloma Mouse Model

Azacitidine and Lenalidomide Combination In Higher-Risk Myelodysplastic Syndromes-Preliminary Results Of The Vilen-01 Protocol

Erythropoietin Treatment Is Associated with Decreased Blood Glucose Levels: A Preliminary Study in Hematologic Patients

Erythropoietin Treatment Leads to Reduced Blood Glucose Levels and Body Mass: Insights From Murine Models.

Erythropoietin Treatment Is Associated with Augmented Immune Response to the Influenza Vaccine in Hematologic Patients.

T-Cell Abnormalities in Patients with Myelodysplastic Syndromes: Improved Immunological Functions in Patients Treated with Recombinant Erythropoietin.

Erythropoietin Treatment in Advanced Multiple Myeloma Is Associated with Improved Immunological Functions: Could It Be Beneficial in Early Disease?.

Improved Glycemic Control in Diabetic Patients Treated with Recombinant Human Erythropoietin.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only